WEST PHARMACEUTICAL SERVICES, INC. Long-term Debt, Gross
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Long-term Debt, Gross of $203.00 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2026-07-23
- 2026-06-30: Long-term Debt, Gross $203.00M.
- 2026-03-31: Long-term Debt, Gross $203.00M.
- 2025-12-31: Long-term Debt, Gross $203.00M.
- 2025-09-30: Long-term Debt, Gross $203.00M.
| Period end | Long-term Debt, Gross | Long-term Debt, Gross as first filed |
|---|---|---|
| 2026-06-30 | $203.00M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $203.00M 10-Q · filed 2026-04-23 | |
| 2025-12-31 | $203.00M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $203.00M 10-Q · filed 2025-10-23 | |
| 2025-06-30 | $203.00M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $203.00M 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $203.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $203.00M 10-Q · filed 2024-10-24 | |
| 2024-06-30 | $205.90M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $206.40M 10-Q · filed 2024-04-25 | |
| 2023-12-31 | $207.00M 10-K · filed 2025-02-18 | |
| 2023-09-30 | $207.50M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $208.10M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $208.60M 10-Q · filed 2023-04-27 | |
| 2022-12-31 | $209.20M 10-K · filed 2024-02-20 | |
| 2022-09-30 | $209.80M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $252.40M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $252.90M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $253.50M 10-K · filed 2023-02-21 | |
| 2021-09-30 | $254.60M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $254.60M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $255.20M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $255.70M 10-K · filed 2022-02-22 | |
| 2020-09-30 | $256.40M 10-Q · filed 2020-10-23 | |
| 2020-06-30 | $256.90M 10-Q · filed 2020-07-24 | |
| 2020-03-31 | $257.40M 10-Q · filed 2020-04-24 | |
| 2019-12-31 | $258.00M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $195.60M 10-Q · filed 2019-10-29 | |
| 2019-06-30 | $196.50M 10-Q · filed 2019-07-29 | |
| 2019-03-31 | $196.10M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $196.70M 10-Q · filed 2019-10-29 | |
| 2018-09-30 | $196.80M 10-Q · filed 2018-10-30 | |
| 2018-06-30 | $197.00M 10-Q · filed 2018-07-31 | |
| 2018-03-31 | $198.00M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $197.70M 10-Q · filed 2018-10-30 | $197.00M 10-Q · filed 2018-05-08 |
| 2017-10-02 | $33.10M 10-Q · filed 2017-10-31 | |
| 2017-09-30 | $229.80M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $229.50M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $228.60M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $228.60M 10-Q · filed 2017-10-31 | |
| 2016-09-30 | $232.10M 10-Q · filed 2016-10-31 | |
| 2016-06-30 | $232.30M 10-Q · filed 2016-08-01 | |
| 2016-03-31 | $233.00M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $299.20M 10-Q · filed 2016-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |